Tests:Cholesterol-HDL Ratio, Plasma: Difference between revisions
- Department
- Biochemistry
- Also at
- Hawera
Tests:Cholesterol-HDL Ratio, Plasma
No edit summary |
No edit summary |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
[[Category:Tests]] | [[Category:Tests]] | ||
[[Category:Biochemistry]] | [[Category:Biochemistry]] | ||
[[Category:Hawera]] | |||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Overview == | ||
|- | |- | ||
|Department | |Department | ||
| Line 14: | Line 15: | ||
|Synonyms | |Synonyms | ||
|Lipid profile | |Lipid profile | ||
|- | |||
|Base Lab Availability | |||
|Monday - Sunday, testing routinely available out of hours | |||
|- | |||
|Hawera Lab Availability | |||
|Monday- Friday, 8am to 4 30pm | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
| Line 22: | Line 29: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Specimen Requirements == | ||
|- | |||
|Specimen | |||
|Plasma | |||
Serum | |||
|- | |- | ||
| | |Preferred | ||
|6 mL <span style="background:#e30022"> | |6 mL <span style="background:#e30022"> Red-Top</span> | ||
|- | |- | ||
| | |Acceptable | ||
| | |4 mL Li-Hep <span style="background:#3cb371"> Green-Top </span> | ||
|- | |- | ||
| | |Unacceptable | ||
| | | | ||
|- | |- | ||
| | |Specimen Transportation | ||
| | | | ||
|- | |- | ||
| | |Paediatric Requirements | ||
| | |600 µL <span style="background:#99e6b3"> Li-Hep Microtainer </span> | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Aliquot Requirements == | ||
|- | |||
|Sample | |||
| | |||
|- | |- | ||
| | |Preferred Volume | ||
| | | | ||
|- | |- | ||
| Line 48: | Line 62: | ||
| | | | ||
|- | |- | ||
|Aliquot Transportation | | Aliquot Transportation | ||
| | | | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Clinical Information == | ||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| | | | ||
|- | |- | ||
|Test Method | |Test Method | ||
|Abbott Enzymatic reagent on the Abbott Architect ci8200 analyser | |Abbott Enzymatic reagent on the Abbott Architect ci8200 analyser | ||
|- | |- | ||
| Line 67: | Line 81: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Comments == | ||
|- | |- | ||
| colspan="2" |Help for Lipid Studies Interpretation | | colspan="2" |''Help for Lipid Studies Interpretation'' | ||
Reported Comments: | Reported Comments: | ||
1. All reports get this comment (see below for additional information on optimal | 1. All reports get this comment (see below for additional information on optimal levels): | ||
levels) | |||
" | "Optimal levels are suggested by the New Zealand Guidelines Group though an individualised multi-factorial approach is preferred." | ||
2. All reports get this comment, unless superseded by anyone or more of the other comments below: | |||
greater than | "Cardiovascular risk should be addressed by lifestyle and pharmacological interventions in subjects with 5-year CV risk greater than 15%." | ||
3. Total | 3. Total cholesterol >8 mmol/L or Total cholesterol/HDL ratio >8: | ||
|} | |} | ||
{{DocMeta | |||
| owner = Crossley1 | |||
| review_ping = | |||
}} | |||
Latest revision as of 09:27, 3 October 2025
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | LIPS |
| Synonyms | Lipid profile |
| Base Lab Availability | Monday - Sunday, testing routinely available out of hours |
| Hawera Lab Availability | Monday- Friday, 8am to 4 30pm |
| Turnaround Time | 2 hours |
| Stability – Add test | 24 hours |
Specimen Requirements | |
| Specimen | Plasma
Serum |
| Preferred | 6 mL Red-Top |
| Acceptable | 4 mL Li-Hep Green-Top |
| Unacceptable | |
| Specimen Transportation | |
| Paediatric Requirements | 600 µL Li-Hep Microtainer |
Aliquot Requirements | |
| Sample | |
| Preferred Volume | |
| Minimum Volume | |
| Aliquot Transportation | |
Clinical Information | |
| Reference Intervals | |
| Test Method | Abbott Enzymatic reagent on the Abbott Architect ci8200 analyser |
| Advanced Notice | |
| Patient Preparation | |
Comments | |
| Help for Lipid Studies Interpretation
Reported Comments: 1. All reports get this comment (see below for additional information on optimal levels): "Optimal levels are suggested by the New Zealand Guidelines Group though an individualised multi-factorial approach is preferred." 2. All reports get this comment, unless superseded by anyone or more of the other comments below: "Cardiovascular risk should be addressed by lifestyle and pharmacological interventions in subjects with 5-year CV risk greater than 15%." 3. Total cholesterol >8 mmol/L or Total cholesterol/HDL ratio >8: | |
| Owner | Clair Crossley (Crossley1) |
|---|---|
| Last reviewed | 3 Oct 2025 |
| Next review | Overdue, 3 Oct 2026 |